Alliance Global lowered the firm’s price target on Curaleaf (CURLF) to C$5.50 from C$6 and keeps a Buy rating on the shares after the company reported a “slight” Q4 sales beat. The firm views Curaleaf as having taken steps to stabilize its domestic business, with international still providing growth opportunities, the analyst tells investors.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CURLF:
- Curaleaf Posts Higher 2025 Revenue as International Cannabis Growth Accelerates
- Curaleaf reports Q4 adjusted cont ops EPS (5c) consensus (9c)
- Curaleaf opens newest dispensary in Findlay, Ohio
- Curaleaf Closes Record US$500 Million Note Offering, Extends Debt Maturities to 2029
- Curaleaf Delays Special Meeting, Plans Combined Vote on Move to Delaware